Shearit, LLC
June 25, 2026
5B
Type: Start-Up Stadium Session
Focus Area:
Cardiovascular
Cerebral Ischemia or low cerebral blood flow (CBF) and microvascular shunts (MVS) is the final common pathway of brain injury in a broad spectrum of disorders such as stroke, cerebral small vessel disease, vascular dementia, Alzheimer’s Disease, Lupus, multiple sclerosis, traumatic brain injury (TBI), cerebrovascular accidents (CVA) such as subarachnoid hemorrhage, intracerebral hemorrhage, Shearit™ developed the application of LAMIFLO™ a high molecular weight polyethylene oxide (PEO) drag reducing polymer by improving the physical dynamics of blood and red blood cell (RBC) flow thereby mitigating the effects of low cerebral blood flow (CBF), an important mechanism of injury in cerebrovascular diseases
Company HQ City:
Albuquerque
Company HQ State:
NM
Company HQ Country:
United States
Year Founded:
2017
CEO
Edwin M. Nemoto
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}